Inna Z. Gaydukova

Nevsky Avenue, 86
Saint Petersburg, SPE 191025, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

The Efficacy and Safety of Divozilimab in Patient with Systemic Sclerosis: 48-Week Results of the Randomized Double-Blind Placebo-Controlled Phase III Clinical Study LIBERIUS.

The Efficacy and Safety of Divozilimab in Patient with Systemic Sclerosis: 48-Week Results of the Randomized Double-Blind Placebo-Controlled Phase III Clinical Study LIBERIUS.

Journal: Doklady. Biochemistry and biophysics

Published: February 20, 2026

Variability of Psoriatic Arthritis Impact of Disease questionnaire (PsAID12) thresholds in psoriatic arthritis: data from the ReFlaP study.

Variability of Psoriatic Arthritis Impact of Disease questionnaire (PsAID12) thresholds in psoriatic arthritis: data from the ReFlaP study.

Journal: Rheumatology (Oxford, England)

Published: August 09, 2024

Outcomes of a 12-month course of early and late rituximab BCD020 biosimilar administration in juvenile systemic lupus erythematosus: A retrospective study.

Outcomes of a 12-month course of early and late rituximab BCD020 biosimilar administration in juvenile systemic lupus erythematosus: A retrospective study.

Journal: World journal of nephrology

Published: June 25, 2024

Real-World Retention Rate, Effectiveness, and Safety of Netakimab in the Treatment of Patients with Ankylosing Spondylitis: First Year Results of the LIBRA Post-Registration Safety Study.

Real-World Retention Rate, Effectiveness, and Safety of Netakimab in the Treatment of Patients with Ankylosing Spondylitis: First Year Results of the LIBRA Post-Registration Safety Study.

Journal: Doklady. Biochemistry and biophysics

Published: May 10, 2024

Patient-defined flares and disease activity worsening in 222 patients with psoriatic arthritis from 14 countries.

Patient-defined flares and disease activity worsening in 222 patients with psoriatic arthritis from 14 countries.

Journal: Joint bone spine

Published: September 09, 2022

Response to netakimab in radiographic axial spondyloarthritis patients with different baseline C-reactive protein, sacroiliitis evaluated by MRI and peripheral joint involvement status: a post-hoc analysis of the ASTERA study.

Response to netakimab in radiographic axial spondyloarthritis patients with different baseline C-reactive protein, sacroiliitis evaluated by MRI and peripheral joint involvement status: a post-hoc analysis of the ASTERA study.

Journal: Clinical and experimental rheumatology

Published: February 08, 2022

Residual patient-reported burden in 444 patients with psoriatic arthritis in remission or low disease: A cross-sectional analysis.

Residual patient-reported burden in 444 patients with psoriatic arthritis in remission or low disease: A cross-sectional analysis.

Journal: Joint bone spine

Published: November 14, 2021

Disparities in healthcare in psoriatic arthritis: an analysis of 439 patients from 13 countries.

Disparities in healthcare in psoriatic arthritis: an analysis of 439 patients from 13 countries.

Journal: RMD open

Published: October 14, 2021

Development of an environmental contextual factor item set relevant to global functioning and health in patients with axial spondyloarthritis.

Development of an environmental contextual factor item set relevant to global functioning and health in patients with axial spondyloarthritis.

Journal: Rheumatology (Oxford, England)

Published: April 21, 2021

Improving benefit-harm assessment of glucocorticoid therapy incorporating the patient perspective: The OMERACT glucocorticoid core domain set.

Improving benefit-harm assessment of glucocorticoid therapy incorporating the patient perspective: The OMERACT glucocorticoid core domain set.

Journal: Seminars in arthritis and rheumatism

Published: April 05, 2021

Spondyloarthritis: modern terminology and definitions

Spondyloarthritis: modern terminology and definitions

Journal: Terapevticheskii arkhiv

Published: April 16, 2020

Determinants of sleep impairment in psoriatic arthritis: An observational study with 396 patients from 14 countries.

Determinants of sleep impairment in psoriatic arthritis: An observational study with 396 patients from 14 countries.

Journal: Joint bone spine

Published: November 26, 2019

Showing 1-12 of 29

Last Updated: 09/26/2026